scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1537-2995.1994.341195065031.X |
P698 | PubMed publication ID | 7974703 |
P2093 | author name string | Kwong YL | |
Chan TK | |||
Lee AC | |||
Yuen KY | |||
Lau YL | |||
Wong S | |||
Lie AK | |||
Ng MH | |||
Liang R | |||
Chiu EK | |||
P433 | issue | 11 | |
P921 | main subject | platelet transfusion | Q23925170 |
P304 | page(s) | 950-954 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | A prospective study of symptomatic bacteremia following platelet transfusion and of its management | |
P478 | volume | 34 |
Q43030574 | A prospective study to determine the frequency of bacterial contamination of platelets |
Q34326677 | Association of Laribacter hongkongensis in community-acquired gastroenteritis with travel and eating fish: a multicentre case-control study. |
Q53724518 | Bacterial complications of blood transfusions |
Q33719334 | Bacterial contamination of blood components |
Q34522392 | Bacterial contamination of blood products: factors, options, and insights |
Q35807467 | Bacterial contamination of cellular blood components: risks, sources and control |
Q33397311 | Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis |
Q34451446 | Bacterial contamination of platelet concentrates: incidence, significance, and prevention |
Q50131406 | Clinical significance of alimentary tract microbes in bone marrow transplant recipients |
Q41484589 | Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates |
Q53909708 | Compodock, a new device for sterile docking. |
Q33769745 | Considerations in the selection of a platelet component: apheresis versus whole blood-derived |
Q33579171 | Current methods for the preparation of platelet concentrates: laboratory and clinical aspects |
Q33338131 | Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study |
Q40638359 | Diagnostic difficulties of transfusion incidents due to bacterial contamination: report of two cases |
Q28168715 | Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days |
Q52545960 | Electrochemiluminescent detection of bacteria in blood components. |
Q34464623 | Freeze-dried blood cells: therapeutic advance or laboratory curiosity? |
Q34153169 | Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. |
Q46401345 | In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools |
Q30328537 | Inactivation of infectious pathogens in labile blood components: meeting the challenge. |
Q30431256 | Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates |
Q77925242 | Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives |
Q37208873 | Incidence of bacterial transmission and transfusion reactions by blood components |
Q34022474 | Leucocyte depletion of the blood supply - how will patients benefit? |
Q40592824 | Methicillin-resistant Staphylococcus aureus sepsis associated with the transfusion of contaminated platelets: a case report |
Q33361167 | Optimizing platelet transfusion therapy |
Q33332598 | Pharmacologic treatment options in patients with thrombocytopenia |
Q43655377 | Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function |
Q41461282 | Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria |
Q54260245 | Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases. |
Q33581221 | Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective |
Q46866924 | Prevalence of bacterial contamination of standard platelet units: prospective study |
Q54439376 | Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. |
Q43980864 | Quality assurance of bacterial incidents associated with blood transfusion |
Q44921346 | Quantitative bacteriological evaluation of a method for skin disinfection in blood donors |
Q37208865 | Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products |
Q40834176 | Rapid screening method for detection of bacteria in platelet concentrates |
Q44849799 | Reduction of platelet transfusion- associated sepsis by short-term bacterial culture |
Q37209101 | Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components |
Q35122220 | Risks associated with transfusion of cellular blood components in canada |
Q33328995 | Risks, costs, and alternatives to platelet transfusions |
Q32044829 | Transfusion incidents related to bacterial contamination: review of the literature and hemovigilance data. For the working group Bacterial incidents of French Blood Agency, scientific advice of Bacthem and the French hemovigilance network |
Q35064110 | Transfusion medicine for the pediatrician |
Q33370536 | Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study |
Q35743767 | Transfusion-transmitted bacterial infection: risks, sources and interventions |
Q82261297 | What Was in Those Platelets? |
Q73577980 | [Blood transfusion and bacterial risk] |
Q74086190 | [Blood transfusion and bacterial risk] |
Q79789964 | [New container of sample: role in the reduction of bacterial contamination of standard platelet units] |
Search more.